Rebekah Michelle Case, MD
Family Practice · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Case’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A163222 · Current
Licensed to practise in California · since 2019 · expires 2027-06-30 · University of Iowa Roy J. and Lucille A. Carver College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Year by year
| 2019 | 156 | 459 | 66 | 1.47 | $59,953 | $24,457 |
| 2018 | 216 | 1,032 | 64 | 1.59 | $134,888 | $63,285 |
| 2017 | 157 | 791 | 64 | 1.76 | $106,450 | $49,934 |
| 2016 | 161 | 635 | 64 | 1.48 | $84,936 | $45,133 |
| 2015 | 65 | 113 | 65 | 1.30 | $13,455 | $6,353 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 7 services
| Return visit (30+ min) | 126 | $10,895 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $2,887 | $115 |
| Short return visit (20+ min) | 51 | $2,651 | $45 |
| Pneumococcal vaccine, 23-valent | 11 | $1,187 | $108 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $465 | $42 |
| Hemoglobin a1c level | 32 | $370 | $11 |
| Administration of pneumococcal vaccine | 19 | $308 | $16 |
2018: 15 services
| Return visit (30+ min) | 168 | $27,553 | $73 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 57 | $6,526 | $114 |
| Short return visit (20+ min) | 95 | $6,460 | $47 |
| New patient visit (45+ min) | 45 | $4,749 | $106 |
| Pneumococcal vaccine, 13-valent | 22 | $4,361 | $198 |
| Pneumococcal vaccine, 23-valent | 19 | $2,006 | $106 |
| Influenza vaccine split virus, preservative free | 34 | $1,778 | $52 |
| Administration of influenza virus vaccine | 50 | $995 | $20 |
| Destruction of precancer skin growth, 1 growth | 19 | $924 | $42 |
| Administration of pneumococcal vaccine | 40 | $796 | $20 |
| Hemoglobin a1c level | 31 | $635 | $12 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 12 | $504 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $252 | $12 |
| Destruction of precancer skin growth, 2-14 growths | 12 | $50 | $4 |
| Automated urinalysis test | 11 | $30 | $3 |
2017: 14 services
| Return visit (30+ min) | 110 | $23,326 | $76 |
| Short return visit (20+ min) | 73 | $5,874 | $50 |
| New patient visit (45+ min) | 51 | $5,136 | $101 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $3,501 | $113 |
| Pneumococcal vaccine, 13-valent | 15 | $2,764 | $184 |
| Destruction of precancer skin growth, 1 growth | 24 | $1,451 | $45 |
| Pneumococcal vaccine, 23-valent | 14 | $1,295 | $93 |
| Influenza vaccine split virus, preservative free | 26 | $1,249 | $48 |
| Administration of influenza virus vaccine | 40 | $981 | $25 |
| Administration of pneumococcal vaccine | 29 | $711 | $25 |
| Hemoglobin a1c level | 19 | $300 | $13 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 14 | $261 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $132 | $10 |
| Destruction of precancer skin growth, 2-14 growths | 16 | $92 | $4 |
2016: 11 services
| Return visit (30+ min) | 90 | $17,408 | $92 |
| Short return visit (20+ min) | 108 | $9,475 | $58 |
| New patient visit (45+ min) | 55 | $7,191 | $131 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,561 | $130 |
| Pneumococcal vaccine, 23-valent | 12 | $1,058 | $88 |
| Administration of influenza virus vaccine | 34 | $819 | $24 |
| Influenza vaccine split virus, preservative free | 17 | $712 | $42 |
| Administration of pneumococcal vaccine | 21 | $506 | $24 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 15 | $262 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $210 | $14 |
| Hemoglobin a1c level | 12 | $156 | $13 |
2015: 2 services
| Short return visit (20+ min) | 34 | $2,193 | $55 |
| New patient visit (45+ min) | 15 | $1,810 | $121 |
Medicaid work
$5,381 in 2019
Medicaid paid $5,381 for 131 billed services this clinician did in 2019, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 131 | $5,381 |
| 2019 | 131 | 1 | 27 | $5,381 |
| 2018 | 357 | 2 | 31 | $12,099 |
See the largest Medicaid services in earlier years
2018
| Return visit (30+ min) | 314 | $11,039 |
| Short return visit (20+ min) | 43 | $1,059 |
Money from drug and device companies
$48 in 2019
A payment is not proof that care is biased.
| Pfizer | Toviaz | $48 | 2 payments
|
See all 2 published payments
| Pfizer | Meals · 2019-04-11 | Toviaz | $27 |
| Pfizer | Meals · 2019-04-10 | Toviaz | $21 |
Professional record
- NPI
- 1730455932
- Licence
- CA A163222, MO 2015015606, WI 61381California A163222: Current · expires 2027-06-30
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-04-02
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1390 US Highway 61, Festus, MO, 63028